Validating Time‐Series Regression Model Predictions of Influenza Mortality: An Interrupted Time‐Series Analysis
5 affiliations
- 1Department of Infectious Diseases University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne Australia
- 2WHO Collaborating Centre for Reference and Research on Influenza Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity Melbourne Australia
- 3Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health University of Melbourne Melbourne Australia
- 4School of Clinical Sciences Monash University Clayton Australia
- 5Monash Infectious Diseases Monash Health Clayton Australia
Abstract
Background: In Australia, non‐pharmaceutical interventions introduced early in 2020 to curtail the spread of COVID‐19 resulted in the temporary elimination of influenza. We used data from this influenza‐free period (2021) to validate influenza mortality burden predictions from time‐series models.
Methods: Time‐series models were parameterised with routinely collected health data from 2010 to 2019 (pre‐pandemic) and from 2010 to 2019 plus 2021 (pandemic‐inclusive). These models were used to predict influenza A‐ and influenza B‐associated mortality rates in Queensland between 2010 and 2019. Mortality estimates were made in persons < 65 and ≥ 65 years for pneumonia and influenza (P&I) and respiratory illnesses as contributory mortality causes and for all‐cause mortality.
Results: The models predicted consistent mortality rates for influenza B. However, the pandemic‐inclusive model for individuals ≥ 65 years predicted influenza A‐associated P&I mortality of 32.1 per 100,000 person‐years (95% prediction interval [PI]: 25.9, 39.6), significantly higher than the pre‐pandemic model estimate of 17.6 (95% PI: 13.4, 23.6). A similar, non‐significant difference occurred for respiratory mortality.
Conclusions: These results suggest that time‐series modelling may underestimate the true burden of influenza‐A mortality among the elderly. Further studies are needed to confirm this finding and establish the conditions under which the time‐series regression approach may be reliable.
Related
- Nursing workforce trends in Kazakhstan, 2003–2024: an interrupted time series and joinpoint regression analysis in the context of educational reform
- Impact of Chile’s Explicit Health Guarantees Policy on breast cancer mortality: an interrupted time series analysis (1990–2024)
- Towards Interpretable Risk: Multidimensional Context for ICU Mortality Predictions
- Divergent suicide mortality trends across South America, 2000–2021: a 12-country joinpoint regression analysis by sex
- Costs of influenza-associated healthcare: an umbrella review and meta-regression analysis
BibTeX
@article{goldsmith2026validating,
title = {{Validating Time‐Series Regression Model Predictions of Influenza Mortality: An Interrupted Time‐Series Analysis}},
author = {Jessie J. Goldsmith and David J. Price and Katherine B. Gibney and Patricia Therese Campbell and Sheena G. Sullivan},
journal = {Influenza and other respiratory viruses},
year = {2026},
month = nov,
doi = {10.1111/irv.70340},
url = {https://europepmc.org/article/PMC/PMC13730788},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Validating Time‐Series Regression Model Predictions of Influenza Mortality: An Interrupted Time‐Series Analysis
AU - Jessie J. Goldsmith
AU - David J. Price
AU - Katherine B. Gibney
AU - Patricia Therese Campbell
AU - Sheena G. Sullivan
PY - 2026
DA - 2026/11/01
JO - Influenza and other respiratory viruses
DO - 10.1111/irv.70340
UR - https://europepmc.org/article/PMC/PMC13730788
AB - Background: In Australia, non‐pharmaceutical interventions introduced early in 2020 to curtail the spread of COVID‐19 resulted in the temporary elimination of influenza. We used data from this influenza‐free period (2021) to validate influenza mortality burden predictions from time‐series models. Methods: Time‐series models were parameterised with routinely collected health data from 2010 to 2019 (pre‐pandemic) and from 2010 to 2019 plus 2021 (pandemic‐inclusive). These models were used to predict influenza A‐ and influenza B‐associated mortality rates in Queensland between 2010 and 2019. Mortality estimates were made in persons < 65 and ≥ 65 years for pneumonia and influenza (P&I) and respiratory illnesses as contributory mortality causes and for all‐cause mortality. Results: The models predicted consistent mortality rates for influenza B. However, the pandemic‐inclusive model for individuals ≥ 65 years predicted influenza A‐associated P&I mortality of 32.1 per 100,000 person‐years (95% prediction interval [PI]: 25.9, 39.6), significantly higher than the pre‐pandemic model estimate of 17.6 (95% PI: 13.4, 23.6). A similar, non‐significant difference occurred for respiratory mortality. Conclusions: These results suggest that time‐series modelling may underestimate the true burden of influenza‐A mortality among the elderly. Further studies are needed to confirm this finding and establish the conditions under which the time‐series regression approach may be reliable.
SN - 1750-2640
SN - 1750-2659
ER -